Characteristics of patients initiating teriparatide for the treatment of osteoporosis

@article{Foster2007CharacteristicsOP,
  title={Characteristics of patients initiating teriparatide for the treatment of osteoporosis},
  author={Shonda A. Foster and Kathleen Anne Foley and Eric S. Meadows and Joseph Atkins Johnston and Suxiang Wang and Gerhardt M. Pohl and Stacey R. Long},
  journal={Osteoporosis International},
  year={2007},
  volume={19},
  pages={373-377}
}
The demographic and clinical characteristics of patients initiating teriparatide were compared with those of patients initiating bisphosphonates for the treatment of osteoporosis. In these samples of commercially insured, Medicare, and Medicaid patients, patients initiating teriparatide were older, in poorer health, and appeared to have more severe osteoporosis than patients initiating bisphosphonates. The demographic and clinical characteristics of patients initiating teriparatide are compared… CONTINUE READING
BETA

Tables and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-6 OF 6 REFERENCES

Osteoporosis : Clinical management guidelines for the obstetriciangynecologist

  • RM Neer, CD Arnaud
  • Obstet Gynecol
  • 2004

Forteo ( teriparatide ) by Eli Lilly and Company

  • RA Deyo, DC Cherkin, MA Ciol
  • 2002

Similar Papers

Loading similar papers…